The grey zone between autoimmune encephalitis and autoimmune-associated epilepsy

Autori: Morano A, Cerulli Irelli E, Fanella M, Zuliani L, Giallonardo AT, Di Bonaventura C.

Data: 2021

Ambito di interesse: Epilessia/malattie autoimmuni del SNC

Rivista: Epilepsia Open. 2021 Nov 15

Potrebbero interessarti anche:

Rivista 14,6

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

Autori: Vitale a

Data: 15 mar 2023

Ambito di interesse: epatologico

Rivista: J Hepatolo

Leggi dettagli

Rivista 3.083

A case of oralmycosisfungoidessuccessfullytreated by combination of alemtuzumab and chemotherapy

Autori: Postorino M, Pupo L, Provenzano I, Del Principe MI, Buccisano F, Franceschini L, Rizzo M, Nasso D, Meconi F, Onnis I, Vaccarini S, Zizzari A, Anemona L, Mauramati S, Bruno E, Cantonetti M, Amadori S.

Data: 2015

Ambito di interesse: Ematologia

Rivista: ANNALS OF HEMATOLOGY 2016 PMID:26442854.

Leggi dettagli

Rivista 12.34

Faciobrachial dystonic seizures: the borderland between epilepsy and movement disorders.

Autori: Alessandra Morano, Martina Fanella, Anna Teresa Giallonardo, Carlo Di Bonaventura.

Data: 2020

Ambito di interesse: Epilessia

Rivista: Mov Disord Clin Pract. 2020;7:228-229

Leggi dettagli

The grey zone between autoimmune encephalitis and autoimmune-associated epilepsy

Potrebbero interessarti anche:

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

A case of oralmycosisfungoidessuccessfullytreated by combination of alemtuzumab and chemotherapy

Faciobrachial dystonic seizures: the borderland between epilepsy and movement disorders.

Cosa fare per